Furthermore, growth of BT-474 derived tumor xenografts was inhibited in vivo and although both compounds reduced expression of ERα and markers of angiogenesis, while inducing ERβ expression and increasing apoptosis, a combination of the two enhanced these effects significantly over either agent alone. The gene discussed is ESR1; the disease is neoplasm.